Displaying 1 - 2 of 2
| Active Ingredient | ATORVASTATIN |
| Therapeutic Class | HMG-CoA REDUCTASE INHIBITORS |
| Indications |
Effective in the treatment of hyper-cholesterolemia and hypertrigly ceridemia. |
| Caution | Headache, diarrhoea, flatulence and mild elevations in liverenzymes. The risk of myopathy and/or rhabdomyolysis is increased when atorvastatin is taken concomitantly with cyclosporine, gemfibrozil, More ... |
| Dose Range |
Adult: Initial dose 10-20mg once daily. The dose may be adjusted at intervals of at least 4 weeks up to a maximum of 80 mg daily . See BDS supply protocols pg. 6. |
| Drug Interactions | |
| Pregnancy | Statins should be avoided in pregnancy (discontinue 3 months before attempting t More ... |
| Breast Feeding | Avoid use of atorvastatin in lactating women. |
| Active Ingredient | AMLODIPINE | ATORVASTATIN |
| Therapeutic Class | ANTILIPEMIC MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |